 |
| Jim Weiss |
W2O Group chief Jim Weiss continues his firm’s acquisition binge by adding Swoop and IPM.ai data-driven technology firms to its line-up.
Swoop and IPM.ai uses machine learning, artificial intelligence and real-world data to solve healthcare challenges.
Swoop creates precise patient audiences, improves targeting of services and empowers people to take active roles in their treatments, while IPM.ai uncovers ideal patients to accelerate R&D and commercialization of therapies.
The addition of the firms will “help our clients move faster and with more precision and efficiency to conduct clinical trials, launch new products, maximize peak revenue opportunities and successfully negate product lifecycles,” said Weiss.
W2O has created a health technology business unit to house Swoop, IPM.ai, Symplur and data/analytics software assets under Adam Cossman, group VP and HTB managing partner.
The San Franciso-based firm has made nine acquisitions since it unveiled its partnership with New Mountain Capital in 2019.
It is O’Dwyer’s top-ranked healthcare firm with 2019 fees of $218.9M.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
